期刊
CANCER AND METASTASIS REVIEWS
卷 31, 期 1-2, 页码 375-386出版社
SPRINGER
DOI: 10.1007/s10555-012-9348-x
关键词
Hakai; E3 ubiquitin-ligase; E-cadherin; Epithelial-mesenchymal transition
类别
资金
- Secretaria Xeral I + D + I, Xunta de Galicia, Spain [IPP.08-07, 10CSA916023PR]
- Conselleria de Sanidade, Xunta de Galicia, Spain [PS09/24]
In order to metastasize, cancer cells must first detach from the primary tumor, migrate, invade through tissues, and attach to a second site. Hakai was discovered as an E3 ubiquitin-ligase that mediates the posttranslational downregulation of E-cadherin, a major component of adherens junctions in epithelial cells that is characterized as a potent tumor suppressor and is modulated during various processes including epithelial-mesenchymal transition. Recent data have provided evidences for novel biological functional role of Hakai during tumor progression and other diseases. Here, we will review the knowledge that has been accumulated since Hakai discovery 10 years ago and its implication in human cancer disease. We will highlight the different signaling pathways leading to the influence on Hakai and suggest its potential usefulness as therapeutic target for cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据